Tempus

cancer target detection radiopharma radio
Favicon Fierce Biotech

Tempus buys out Personalis in $1.5 billion deal

Tempus is boosting its cancer offerings with a deal to buy out Personalis three years after the pair first teamed up in oncology.
Ben Adams Jul 20, 2026 9:55am
The Golden Gate Bridge in San Francisco

JPM26, Day 1: The Fierce Healthcare Monday roundup

Jan 12, 2026 7:30pm
Graphic image of two hands shaking with employeesexecutives on the forearms of each shaking hand

Healthcare Dealmakers—UHG-Amedisys deal; Walgreens goes private

Sep 5, 2025 3:00pm
Blood sample microscope study clinical trial lab research
Favicon Fierce Biotech

Tempus claims AI pathology developer Paige in $81M deal

Aug 22, 2025 12:30pm
puzzle pieces merger and acquisition business concept

Healthcare Dealmakers—Cigna closes $3.3B Medicare sell-off, more

Apr 2, 2025 7:35am
A graphic displaying the concept of a stock ticker

Health tech earnings roundup—The hits and misses in Q2

Aug 9, 2024 2:00pm